SACMM abstract design
Welcome to SACMM image

Active Research Support

National

Investigator: Thomas F. Patterson
Source: NIH/NIAID— NO1-AI-30041
Title: New Animal Models for Invasive Aspergillosis
Period: 8/15/03-8/14/10

Investigator: John F. Graybill
Role: Principal Investigator
Source: NIH/NIAID NO1-AI-25475
Title: Drug Development for Opportunistic Infections: Cryptococcus neoformans
Period: 6/28/02-6/27/09

Investigator: Thomas F. Patterson
Role: Principal investigator
Source: NIH/NIDCR 2 RO1-DE11381-04
Title: Fluconazole Resistance in Oropharyngeal Candidiasis
Period: 2000-2005

Investigator: Thomas F. Patterson
Role: Principal investigator
Source: NIH/NIDCR R21-DE015079
Title: Analysis of the Candida albicans Proteome
Period: 8/1/03-5/31/05

Investigator: Brian A. Wickes
Role: Principal Investigator
Source: National Institute of Allergy and Infectious Disease 1R01AI54946-01
Period: 2/03-1/06
Title: Congenic strains from serotype A Cryptococcus neoformans

Investigator: Jose L. Lopez-Ribot
Role: Principal Investigator
Source: NIH/NIAID R03 AI 054447
Title: NRG1 regulation of Candida albicans virulence
Dates: 04/01/2003 to 03/31/2005

Investigator: Jose L. Lopez-Ribot
Role: Principal Investigator
Source: NIH/NIDCR R21 DE 15079
Title: Analysis of the Candida albicans proteome
Dates: 08/01/2003 to 07/31/2005

Investigator: Jose L. Lopez-Ribot
Role: Principal Investigator
Source: Burroughs Wellcome Fund New Investigator in Molecular Mycology
Title: Gene and Protein Expression Profiling in Candida albicans biofilms
Dates: 07/2001-06/2004

Investigator: Yeh, C-K
Role: Principal Investigator
Agency: NIDCR R21(DE15381)
Title: Salivary Stem Cell Identification for Tissue Restoration
Period: 09/01/03 – 8/30/05

 Investigator: Yeh, C-K
Role: Principal Investigator
Title: Cellular signals in isoproterenol induced salivary cell growth
Role: Principal Investigator
Source: Veterans Administration Merit Review
Dates: 01/01/04 – 12/30/07

State/Local:

Investigator: Teresa Quitugua
Role: Co-Primary Investigator
Source: San Antonio Life Sciences Institute
Title: Immunization Against Coccidiodomycosis by Sindbis viruses Expressing Coccidioides Antigens
Dates: 2004-2006

 Investigator: Teresa Quitugua
Role: Primary Investigator
Source: UTHSCSA Institutional Research Grant
Title: Comparative utility of novel SSR analysis to current methods of Mycobacterium tuberculosis strain discrimination
Dates: 2003-2004

Investigator: Teresa Quitugua
Role: Primary Investigator
Source: San Antonio Area Foundation
Title: Multi-Locus VNTR analyses for Molecular Epidemiologic Studies of Tuberculosis
Dates: 2003-2004

Investigator: Teresa Quitugua
Role: Co-Investigator
Agency: Texas Higher Education Coordinating Board
Advanced Research/Advanced Technology Program
Title: Rapid Detection of Drug Resistant Mycobacterium tuberculosis using Two-Dimensional Gene Scanning
Years: 2002-2004

Investigator: Teresa N. Quitugua
Role: Principal Investigator
Source: National Institute of Allergy and Infectious Disease 1 RO1 AI058053-01
Title: Genotyping of Mycobacterium tuberculosis using SSRs
Dates: 03/01/05 – 02/28/08

Other:

Investigator: Thomas F. Patterson
Role: Principal Investigator
Source: Merck
Title: Efficacy and Safety of Caspofungin in a Real World Setting
Period: 2002-2004

Investigator: Thomas F. Patterson
Role: Principal Investigator
Source: Pfizer
Title: Efficacy of Voriconazole Alone and in Combination with Micafungin in a Guinea Pig Model of Invasive Aspergillosis
Period: 2002-2003

Source: McNeil, Inc.
Title: A Double Blind Randomized Vehicle Controlled Study Comparing the Safety and Efficacy of Benzydamine Hydrochloride 0.15% in Subjects with Radiation Induced Oral Mucositis
Dates: 2003-2004

Investigator: Michael G. Rinaldi
Role: Principal Investigator
Source: Ortho-Biotech, Inc.
Title: Antifungal suceptibility testing
Dates: 1/1/00-present

Investigator: Michael G. Rinaldi
Role: Principal Investigator
Source: Pfizer Inc.
Title: Antifungal suceptibility testing
Dates: 1/1/85-present

Investigator: Michael G. Rinaldi
Role: Principal Investigator
Source: Schering-Plough Research Laboratories
Title: Antifungal suceptibility testing
Dates: 1/1/99-present

Investigator: Michael G. Rinaldi
Role: Principal Investigator
Source: Bertek Pharmaceuticals, Inc.
Title: Yearly contract to evaluate antidermatophytic drugs
Dates: 1/1/96-present

Investigator: Michael G. Rinaldi
Role: Principal Investigator
Source: Merck & Co., Inc
Title: In vitro evaluation of caspofungin and standardization of in vitro testing methodology
Dates: 1/1/00-present

Investigator: Michael G. Rinaldi
Role: Principal Investigator
Source: Novartis Pharmaceuticals Corp.
Title: In vitro evaluation of antidermatophytic antifungal drugs
Dates: 1/1/99-present

Investigator: Jose L. Lopez-Ribot
Role: Principal Investigator
Source: Inhibitex, Inc.
Title: Development of Immune-Based Strategies against Candidiasis
Dates: 1/09/02-1/31/05

Investigator: John R. Graybill
Role: Principal Investigator
Source: Schering Plough Research Institute
Title: A Retrospective Study to Estabish an Historical Database on the Efficacy of Standard Antifungal Therapy in Patients with Invasive Fungal Infection. (PO2387-19)
Dates: 09/01/02 - Completion

Investigator: Spencer W. Redding
Role: Principal Investigator
Source: McNeil, Inc.
Title: A Double Blind Randomized Vehicle Controlled Study Comparing the Safety and Efficacy of Benzydamine Hydrochloride 0.15% in Subjects with Radiation Induced Oral Mucositis
Dates: 2003-2004

 
Health Science Center seal

Links provided from Health Science Center pages to other web sites do not constitute or imply an endorsement of those sites, their content, or products and services associated with those sites. Best viewed at 1024x768 resolution.